ITPR2 and acute myeloid leukemia: We previously showed that high expression of ITPR2, which encodes a key regulator of transmembrane calcium ion (Ca2+) transport, was predictive of an adverse outcome for CN-AML patients [15], which stimulated our interest in regulators of metal ion transport.